References
- Dalili H, Adrian J. The efficacy of local anesthetics in blocking the sensations of itch, burning, and pain in normal and “sunburned skin”. Clin Pharmacol Ther 1971;12:913–19.
- Muzzalupo R, Tavano L. Niosomal drug delivery for transdermal targeting: recent advances. Res Rep Transderm Drug Deliv 2015;4:23–33.
- Giese U. Absorption and distribution of ibuprofen from a cream formulation after dermal administration to guinea pigs. Arzneimittelforschung 1990;40:84–8.
- Marianecci C, Di Marzio L, Rinaldi F, et al. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 2014;205:187–206.
- Maibach HI, Choi MJ. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005;18:209–19.
- Carafa M, Marianecci C, Rinaldi F, et al. Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeation. J Liposome Res 2009;19:332–4.
- Marianecci C, Carafa M, Di Marzio M, et al. A new vesicle-loaded hydrogel system suitable for topical applications: preparation and characterization. J Pharm Pharmaceut Sci 2001;14:336–46.
- Di Marzio L, Marianecci C, Rinaldi F, et al. Deformable surfactant vesicles loading ammonium glycyrrhizinate: characterization and in vitro permeation studies. Lett Drug Des Discov 2012;9:494–9.
- Marianecci C, Rinaldi F, Mastriota M, et al. Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models. J Control Rel 2012;164:17–25.
- Marianecci C, Rinaldi F, Di Marzio L, et al. Ammonium glycyrrhizinate-loaded niosomes as potential nanotherapeutic system for anti-inflammatory activity in murine models. Int J Nanomed 2014;9:635–51.
- Wiig H. Pathophysiology of tissue fluid accumulation in inflammation. J Physiol 2011;589:2945–53.
- Lehner R, Wang X, Wolf M, Hunziker P. Designing switchable nanosystems for medical application. J Control Release 2012;161:307–16.
- Masotti A, Vicennati A, Alisi A, et al. Novel Tween-20 derivatives enable the formation of efficient pH-sensitive drug delivery vehicles for human hepatoblastoma. Bioorg Med Chem Lett 2010;20:3021–5.
- Broggi F, Mariani V, et al. Morphological transformation induced by multiwall carbon nanotubes on Balb/3T3 cell model as an in vitro end point of carcinogenic potential. Nanotoxicology 2013;7:221–33.
- Clarke HT, Gillespie HB, Weisshauss SZ. The action of formaldehyde on amines and amino acids. J Am Chem Soc 1933;55:4571–87.
- Di Marzio L, Marianecci C, Petrone M, et al. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. Colloids Surf B Biointerfaces 2011;82:18–24.
- Marianecci C, Rinaldi F, Di Marzio L. Interaction of pH-sensitive non-phospholipid liposomes with cellular mimetic membranes. Biomed Microdevices 2013;15:299–309.
- Carafa M, Marianecci C, Lucania G, et al. New vesicular ampicillin-loaded delivery systems for topical application: characterization, in vitro permeation experiments and antimicrobial activity. J Control Release 2004;95:67–74.
- Marianecci C, Rinaldi F, Di Marzio L, et al. Polysorbate 20 vesicles as multi-drug carriers: in vitro preliminary evaluations. Lett Drug Design Discov 2013;10:212–18.
- Carafa M, Di Marzio L, Marianecci C, et al. Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. Eur J Pharm Sci 2006;28:385–93.
- Hossann H, Wiggenhorn M, Schwerdt A, et al. In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes. Biochim Biophys Acta 2007;1768:2491–9.
- Ponti J, Colognato R, Rauscher H, et al. Colony forming efficiency and microscopy analysis of multi-wall carbon nanotubes cell interaction. Toxicol Lett 2010;197:29–37.
- Pieretti S, Di Giannuario A, De Felice M, et al. Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain 2004;109:52–63.
- Pieretti S, Dominici L, Di Giannuario A, et al. Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors. Life Sci 2006;79:791–800.
- Pippa N, Psarommati F, Pispas S, Demetzos C. The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation. Pharm Res 2013;30:2385–95.
- Goddart ED, Anathapadmanabhan G, Interaction of surfactants with polymers and proteins. Boca Raton, FL: CRC Press; 1993:345–8.
- Carafa M, Santucci E, Lucania G. Lidocaine-loaded non-ionic surfactant vesicles: characterization and in vitro permeation studies. Int J Pharm 2002;231:21–32.
- Mohammed A, Weston N, Coombes AGA, et al. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. Int J Pharm 2004;285:23–34.
- Fattal E, Couvreur P, Dubernet C. “onic pH-sensitive liposomes” delivery of antisense oligonucleotides by anionic pH-sensitive. Adv Drug Deliv Rev 2004;56:931–46.
- dos Santos S, Medronho B, dos Santos T, Antunes FE. Amphiphilic molecules in drug delivery systems. In: Jorge C, ed. Drug delivery systems: advanced technologies potentially applicable in personalised treatment. Amsterdam, the Netherlands: Springer; 2013:35–85.
- Ali MH, Kirby DJ, Mohammed AR, Perrie Y. Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent. J Pharm Pharmacol 2010;62:1646–55.
- Kirby C, Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980;186:591–8.
- Marianecci C, Di Marzio L, Del Favero E, et al. Niosomes as drug nanovectors: multiscale pH-dependent structural response. Langmuir 2016;32:1241–9.
- Pozzi D, Caminiti R, Marianecci C, et al. Effect of cholesterol on the formation and hydration behaviour of solid-supported niosomal membranes. Langmuir 2010;26:2268–73.